Portal
Jacquelyn Sikora Hanson, Ph.D., currently serves as the Director of Applications at Portal, coordinating with early adopters of next-generation mechanoporation technology since 2023. Prior to this role, Jacquelyn was the Associate Director and Platform Development Team Lead at SQZ Biotechnologies from April 2017 to December 2022, where significant advancements were made in the application of squeeze mechanical deformation technology for nucleic acid delivery and genome engineering. Collaborative efforts with external partners and various internal teams were prominent in the execution of innovative projects. Jacquelyn’s academic background includes a Ph.D. in Pathology and Cell and Molecular Biology from Boston University School of Medicine and a B.S. in Biochemistry from Northeastern University, complemented by extensive research experience in regenerative medicine and genetic risk factors in cardiac disease.
This person is not in any teams
Portal
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics